New Transplant Platform Successful in Sickle Cell Doctors Lounge Non-myeloablative conditioning with post-transplantation high-dose cyclophosphamide expands the donor pool for bone marrow transplantation for patients with sickle cell disease, according to a preliminary study published online Sept. 6 in Blood. |
